Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(17%)
Results Posted
25%(2 trials)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
1
8%
Ph phase_1
3
25%
Ph phase_4
5
42%
Ph phase_3
2
17%

Phase Distribution

3

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
5(41.7%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(8)
Other(1)

Detailed Status

Completed8
Recruiting2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (25.0%)
Phase 21 (8.3%)
Phase 32 (16.7%)
Phase 45 (41.7%)
N/A1 (8.3%)

Trials by Status

unknown18%
not_yet_recruiting18%
recruiting217%
completed867%

Recent Activity

2 active trials
Showing 5 of 12
recruitingphase_1

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

NCT07304024
completedphase_1

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects

NCT05964647
not_yet_recruitingphase_3

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

NCT07160790
recruitingnot_applicable

Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.

NCT06654986
completedphase_1

Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics

NCT02177513
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07304024Phase 1

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

Recruiting
NCT05964647Phase 1

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects

Completed
NCT07160790Phase 3

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

Not Yet Recruiting
NCT06654986Not Applicable

Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.

Recruiting
NCT02177513Phase 1

Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics

Completed
NCT01716221Phase 4

An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

Completed
NCT02559440Phase 4

Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy

Completed
NCT01407471Phase 2

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy

Completed
NCT01055704Phase 4

Effect of Methylnaltrexone on GI Transit in Healthy Volunteers

Completed
NCT00471952Phase 3

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache

Completed
NCT00404417Phase 4

Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain

Unknown
NCT00510263Phase 4

Scandinavian Bell's Palsy Study

Completed

All 12 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
12